Startup profile for Avo: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.
Venture Capital Tracker logo
Venture Capital Tracker

Startup profile · funding coverage

Avo funding, valuation and investors

Clinical AI integrating into provider workflows for documentation and care management.

Keep track of Avo

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series A

$10M · April 2026

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$10M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series a

Sources: latest funding Last verified: 2026-07-25

Overview

Avo builds clinical AI tools that embed into provider workflows to reduce documentation burden and improve care management efficiency. The company raised $10M Series A in April 2026 per AlleyWatch funding reports, amid continued investor appetite for healthcare AI that fits EHR/clinic operations without adding compliance risk.

Why Avo is interesting

Clinical AI winners embed in existing workflows — Avo's Series A reflects buyers funding tools that save clinician time, not standalone chatbots.

Product & use cases

Clinical workflow AI for documentation, care coordination, and operational tasks inside provider environments.

  • Reducing physician documentation time
  • Care management task automation
  • Clinical note generation with compliance guardrails

Key facts

  • Series A (Apr 2026): $10M
  • Clinical workflow AI focus
  • AlleyWatch Apr 2026 coverage
  • Healthcare AI integration theme

Funding history (newest first)

Series A

2026-04 $10M

Source: https://www.alleywatch.com/2026/04/the-alleywatch-startup-daily-funding-report-4-1-2026/

Competitive landscape

Edge: April 2026 Series A timing amid health-system AI budgets shifting to proven workflow ROI.

Clinical AI must prove liability-safe documentation and EHR integration; crowded scribe market requires differentiation on specialty workflows or payer alignment.

  • Ambience / Abridge scribes direct

    Ambient clinical documentation startups.

  • Epic AI modules incumbent

    EHR-native AI features.

  • Nuance DAX incumbent

    Microsoft-owned clinical speech solutions.

Notable stories

  • VCT grouped Avo with broader Q1 2026 clinical AI funding concentration per Crunchbase data references.

Industries

Healthtech AI & Machine Learning

Related funding articles

Venture Capital Tracker pieces that cover Avo's financing or category context.

FAQs about Avo

Practical answers founders, operators, and investors typically search for.

Clinical AI integrated into provider workflows for documentation and care tasks.
$10M Series A April 2026.
Competes in clinical AI documentation/workflow space — compare EHR integration depth.
Investors not fully disclosed in AlleyWatch summary reviewed.
Clinical software may fall under SaMD pathways depending on features — verify with company.
Hospitals, clinics, provider groups.
Documentation burden and staffing shortages drive health-system budgets.
No VCT fund ids confirmed in public sources for this round.
United States healthcare AI startup.
Private; not disclosed.
All startups Funding news

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.